Examining the 2020 AACE/ACE Osteoporosis Clinical Guidelines: Featuring Patient Cases

Examining the 2020 AACE/ACE Osteoporosis Clinical Guidelines: Featuring Patient Cases

Faculty Presenter

Jamie L. McConaha, PharmD, NCTTP, BCACP, CDE
Associate Professor of Pharmacy Practice
Duquesne University School of Pharmacy
Pittsburgh, Pennsylvania
 
Program Description
Pharmacists can be involved in all aspects of osteoporosis care, from patient assessment and diagnosis to initiation and management of pharmacotherapy. This third module in the 4-part curriculum series will review patient case studies from initial patient screening and diagnosis to initiation of therapy. The case studies presented incorporate real-world evidence to give pharmacists opportunities to apply the updated 2020 AACE/ACE guidelines. Equipped with this information, pharmacists can assist in determining appropriate use of approved and current agents in osteoporosis treatment as well as in monitoring ongoing treatment.

Target Audience: Specialty pharmacists
Type of Activity: Application
Release date: March 31, 2021
Expiration date: March 31, 2022
Time to complete activity: 1.0 hour
Fee: Free

Educational Objectives
At the completion of this activity, participants will be able to:

• Document the evolution of clinical practice guidelines related to osteoporosis treatment
• Examine the 2020 AACE/ACE guidelines, including the updated algorithm on classification of fracture risk and recommendations for drug therapy
• Explain clinical controversies in osteoporosis treatment, including monitoring drug therapy, duration of therapy, sequential treatment, and combination treatment

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-21-013-H01-P. The activity is available for CE credit through March 31, 2022.


Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, view the webcast in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
 

---

Disclosures

Jamie L. McConaha, PharmD, NCTTP, BCACP, CDE, has no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ Planning Staff – Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Michelle Carlson, PharmD; Brianna Schauer, MBA, PMP; Kelly McCormick; Susan Pordon; and Brianna Winters have no relevant financial relationships with commercial interests to disclose.

An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
ceinfo@pharmacytimes.com
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms